OR WAIT null SECS
© 2021 MJH Life Sciences and Cannabis Patient Care. All rights reserved.
© 2021 MJH Life Sciences™ and Cannabis Patient Care. All rights reserved.
Check out our latest issue focused on chronic pain
July 27, 2021
The partnership will focus on sharing patient and advocate experiences and educating the public on the medical benefits of cannabis.
July 26, 2021
In this roundtable interview series, we speak to each of the organizers to learn more about them and what attends can expect from the practicum. Here in part II, they discuss how cannabis can be used stop opioid addiction and possible ways cannabis might interact with other prescription medications.
July 22, 2021
WeedMD, a federally licensed producer and distributor or medical-grade cannabis, will be rebranding as Entourage Health Corp. over the next few months.
Here, Otha Smith discusses the Tetragram app, which allows users to track cannabis products enabling them to find the best products that suit their needs.
June 28, 2021
As successful owners of the medical cannabis dispensary Greenhouse Wellness, Gina Dubbé and OBGYN Dr. Leslie Apgar share their history and future plans.
In this roundtable interview series, we speak to each of the organizers of the CannMed Medical Practicum to learn more about them and what attends can expect from the practicum. Here in part I, they share some of the clinical applications for medical cannabis and dosing information.
June 24, 2021
NFL-NFLPA Joint Pain Management Committee (PMC) plans to award up to $1 million in grants to CBD and cannabis researchers.
June 15, 2021
Cannabis Patient Care™ is pleased to announce the addition of Dr. Jeff Konin to its editorial advisory board (EAB).
May 24, 2021
In this interview, Maria Enquist-Newman, PhD, Director of R&D Program Management at Demetrix, delves into the specifics of fermentation-produced cannabinoids and how this method can benefit the cannabis industry.
British Journal of Pharmacology published a study' findings that highlighted the ability of Neuropathix’s patented compound KLS-13019 to prevent and reverse chemotherapy-induced peripheral neuropathy (CIPN) in mice.